NRX Pharmaceuticals, Inc. (NRXP) Form 8-K — Jun 4, 2026
NRx Pharmaceuticals, Inc. (NRXP) announced the closing of a public offering of 5,714,286 shares of its common stock at a price of $3.50 per share. The offering was underwritten by BTIG, LLC and Lucid Capital Markets, LLC, and was made pursuant to a previously effective shelf registration statement on Form S-3. The company estimates net proceeds of approximately $18.8 million, or $21.6 million if the underwriters' 30-day option to purchase up to 857,142 additional shares is exercised in full.
Key figures
- Gross Proceeds
- 19999999
- Offering Price
- 3.5
- Shares Offered
- 5714286
- Net Proceeds
- 18800000
- Optional Shares
- 857142
- Lockup Period Days
- 60
- Net Proceeds With Option
- 21600000
- Purchase Price Per Share
- 3.29
- Underwriting Discount Per Share
- 0.21
Price after filing
Close on the filing date to close N calendar days later (from $4.05). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.